Last quarter (Q3 2024), Vaxart's total revenue was $4.93M, an increase of 1006.05% from the same quarter last year. In Q3, Vaxart's net income was $-14.08M. See Vaxart’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 18.41M	$ 7.38M	$ 107.00K	$ 892.00K	$ 4.05M	$ 9.86M
Cost of Revenue	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 16.76M	$ 7.38M	$ 107.00K	$ 892.00K	$ 4.05M	$ 9.86M
Operating Expense	$ 88.46M	$ 90.73M	$ 114.69M	$ 73.64M	$ 34.22M	$ 25.65M
Operating Income	$ -71.70M	$ -83.35M	$ -114.59M	$ -72.75M	$ -30.17M	$ -15.79M
Net Non Operating Interest Income Expense	$ 2.52M	$ 2.65M	$ 58.00K	$ 81.00K	$ 75.00K	$ -166.00K
Other Income Expense	$ ―	$ ―	$ 2.70M	$ 3.00M	$ ―	$ 99.00K
Pretax Income	$ -72.08M	$ -82.20M	$ -107.69M	$ -70.36M	$ -31.98M	$ -18.16M
Tax Provision	$ 258.00K	$ 261.00K	$ 67.00K	$ 107.00K	$ 238.00K	$ 490.00K
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -72.34M	$ -82.47M	$ -107.76M	$ -70.47M	$ -32.22M	$ -6.73M
Basic EPS	$ -0.40	$ -0.57	$ -0.84	$ -0.58	$ -0.36	$ -0.86
Diluted EPS	$ -0.40	$ -0.57	$ -0.84	$ -0.58	$ -0.36	$ -0.86
Basic Average Shares	$ 733.41M	$ 144.82M	$ 127.68M	$ 121.45M	$ 88.30M	$ 21.57M
Diluted Average Shares	$ 733.41M	$ 144.82M	$ 127.68M	$ 121.45M	$ 88.30M	$ 21.57M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 88.46M	$ 90.73M	$ 110.44M	$ 73.64M	$ 34.22M	$ 25.65M
Net Income From Continuing And Discontinued Operation	$ -72.34M	$ -82.47M	$ -107.76M	$ -70.47M	$ -32.22M	$ -18.64M
Normalized Income	$ -30.20M	$ ―	$ ―	$ -52.58M	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -71.60M	$ -80.76M	$ -106.39M	$ -68.88M	$ -30.11M	$ -17.84M
EBITDA	$ -62.66M	$ -72.13M	$ -100.58M	$ -64.67M	$ -27.40M	$ -14.24M

Currency in USD

Vaxart Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing